During your consultation, we evaluate your specific health profile and determine whether semaglutide fits your treatment goals
While everyones experience is unique, many people have lost 15% or more of their starting body weight with tirzepatide
Vein problems can worsen over time, leading to chronic pain, swelling, and even more severe conditions like chronic venous insufficiency (CVI) or deep vein thrombosis (DVT)
By the end of the study, the tirzepatide groups achieved HbA1c reductions of 2.01 percentage points (5 mg dose), 2.24 percentage points (10 mg dose), and 2.30 percentage points (15 mg dose)
B., Knudsen, L
Now, a new study shows that semaglutide (Ozempic, Wegovy) can help people with PAD and diabetes walk farther and also improve their quality of life (see "An already approved drug finds use for PAD")